Stem cell therapy for hard-to-treat type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new stem cell treatment for people with type 2 diabetes that is difficult to control with standard medications. The treatment uses a special kind of stem cell to try to improve blood sugar levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 75 years old
- You have type 2 diabetes with a fasting blood sugar of 7.0 mmol/L or higher
- Your body mass index (BMI) is between 20 and 30
- Your blood sugar control (measured by A1c) is between 7.5% and 10%
- You have been using insulin injections for at least 6 months and your other diabetes drugs have been stable for 3 months
- You are willing to use effective birth control during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if umbilical cord stem cells can improve the success of islet cell transplants for people with diabetes whose own pancreas no longer makes enough insulin. It aims to help patients achieve better blood sugar control and reduce dangerous low blood sugar episodes.
This study tests whether a treatment can help your pancreas make more insulin and possibly put your type 2 diabetes into remission. It is for people diagnosed with type 2 diabetes in the last 5 years who are already on diabetes medication.
This study tests if a single infusion of stem cells from umbilical cord blood can slow kidney damage caused by type 2 diabetes. It may help preserve kidney function and reduce protein in the urine.
This trial tests whether transplanting your own insulin-making cells (islets) can help control blood sugar if you have type 2 diabetes and your pancreas is not making enough insulin. The goal is to reduce or stop your need for insulin injections.
This trial tests a new stem cell treatment (DT2-SCT) for people with type 2 diabetes who need insulin. It aims to see if the treatment is safe and helps control blood sugar better than a placebo.
This trial tests if a type of stem cell product (exosomes) can safely and effectively help people with type 2 diabetes. Researchers will give infusions to see if it improves blood sugar control and pancreatic function.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.